LAUSR

Coronavirus disease 19 (COVID-19) is considered as a multisystemic disease. Several studies have reported persistent symptoms or late-onset complications after acute COVID-19, including post-COVID-19 hematologic disorders. COVID-19- induced coagulopathy, an immunothrombotic state, has been linked to thromboembolic and hemorrhagic events. Late onset thrombocytopenia related to immune system dysregulation has been also reported as a rare manifestation post COVID-19. Close monitoring of laboratory dynamics is considered essential to identify timely abnormal values that need further investigation providing supportive care whenever indicated. The role of hematologists is essential in terms of the multidisciplinary approach of long COVID-19. This review summarizes all the available evidence on post-acute COVID-19 hematological complications. This article is protected by copyright. All rights reserved.